Previous close | 0.0000 |
Open | 0.0241 |
Bid | 0.0212 x 0 |
Ask | 0.0358 x 0 |
Day's range | 0.0241 - 0.0241 |
52-week range | 0.0170 - 0.0610 |
Volume | |
Avg. volume | 225 |
Market cap | 2.206M |
Beta (5Y monthly) | -1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
TORONTO, September 13, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") announces that, further to recent Company press releases reporting that the Company will be exploring certain strategic alternatives (see the Company’s August 13, 2024 and August 7, 2024 press releases), the Company has entered into a non-binding letter of intent (the "LOI") for a proposed transaction. The proposed transaction is subject to, among other things, the negotiation and execution of a
TORONTO, August 13, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), operating as Jack Nathan Health® (the "Company"), one of Canada’s largest healthcare networks, announces that it will evaluate and consider opportunities for strategic options including mergers and acquisitions (M&A). As part of this initiative, a comprehensive data room will be available post-qualification to interested parties. If an agreement for a transaction is signed, further details will be provided by the
TORONTO, August 07, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") reports that it has entered into today an agreement with its secured lender Wal-Mart Canada Corp. (the "Lender") to provide an additional Cdn$474,000 in debt funding (the "Loan"), which provides additional financing for the Company’s operations for the month of August 2024 while the Company concurrently: (a) pursues alternatives to raise additional financing and explore certain strategic alternative